GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Total Receivables

Curocell (XKRX:372320) Total Receivables : ₩8.85 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Total Receivables?

Curocell's Total Receivables for the quarter that ended in Dec. 2024 was ₩8.85 Mil.


Curocell Total Receivables Historical Data

The historical data trend for Curocell's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Total Receivables Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Receivables
Get a 7-Day Free Trial 134.19 558.51 2,084.92 608.84 8.85

Curocell Quarterly Data
Dec19 Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 608.84 656.32 750.83 752.74 8.85

Curocell Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Curocell Total Receivables Related Terms

Thank you for viewing the detailed overview of Curocell's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell Business Description

Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell Headlines

No Headlines